<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03938467</url>
  </required_header>
  <id_info>
    <org_study_id>RVO-IRR-2019</org_study_id>
    <nct_id>NCT03938467</nct_id>
  </id_info>
  <brief_title>Irrisept C.Acnes Study</brief_title>
  <official_title>Effect of Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate (Irrisept) on Incidence of Cutibacterium Acnes in Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthopaedic Associates of Michigan, PC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irrimax Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mercy Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Orthopaedic Associates of Michigan, PC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective, Randomized, Controlled Trial Comparing An Irrisept Antiseptic Irrigation With
      0.05% Chlorhexidine Gluconate versus Standard of Care Prophylaxis Chlorohexidine Wipes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective randomized control trial is to access outcomes of positive
      culture growth of C. acnes from specimens obtained from the shoulders of patients undergoing
      primary shoulder arthroplasty whose intraoperative management includes Irrisept antiseptic
      irrigation and compare it to patients whose management includes standard of care prophylaxis
      wipes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, Randomized, Controlled Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>C.acnes Growth Rate</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the rate of C.acnes using two different antiseptic protocols</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. VAS assessment: [0 (no pain) - 10 (worse possible pain)]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ROM</measure>
    <time_frame>6 Months</time_frame>
    <description>Range of Motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American Shoulder and Elbow Surgeons Shoulder Score (ASES)</measure>
    <time_frame>6 Months</time_frame>
    <description>the Society of the American Shoulder and Elbow Surgeons to facilitate standardization of outcome measures.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Antiseptic Cleanser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard prophylaxis will be administered by Irrisept patients as would individuals in the control group. In addition, these Irrisept study subjects will be supplemented with the use of Irrisept irrigation by the study surgeon during the patient's surgical procedure. Standard times for irrigation will include immediately after incision through the dermal layer, and immediately prior to implantation of any prosthetic components. Final irrigation will be performed just prior to closure of the deltopectoral interval.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Prophylaxis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard prophylaxis includes use of chlorhexidine wipes (Sage cloth) the night before and morning of surgery on the surgical site over the anterior shoulder.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiseptic Cleanser</intervention_name>
    <description>Contains 0.05% Chlorhexidine gluconate in sterile water for irrigation. The mechanical action of the Irrisept system removes bacteria and debris without harming underlying tissues. Irrisept has demonstrated broad spectrum bactericidal activity against antibiotic-resistant strains. Its contents are wrapped in two sequential sterilization wraps which repel water blood, and saline, making it effective against both air and water borne bacteria.</description>
    <arm_group_label>Antiseptic Cleanser</arm_group_label>
    <other_name>Irrisept Wound Cleansing System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has signed the IRB-approved informed consent form specific to this study prior
             to undergoing any research related procedures

          2. Patient can read and understand English

          3. Patient who will undergo a primary shoulder arthroplasty

          4. Patient is over the age of 18

        Exclusion Criteria:

          1. Patient who has had a previous surgery on the ipsilateral shoulder

          2. Patient has a known allergy to topical iodine or Chlorohexidine gluconate.

          3. Patient has had non-surgical prophylaxis antibiotic treatment within 14 days of index
             surgery

          4. Patient requires a revision procedure for a previous ipsilateral shoulder surgery

          5. Patient has any significant pathology that, in the opinion of investigator, makes the
             patient unsuitable for study participation

          6. Patient is a pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Orthopaedic Associates of Michigan, PC</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49525</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Michelle A Padley, MS</last_name>
      <phone>616-459-7101</phone>
      <phone_ext>1797</phone_ext>
      <email>michelle.padley@oamichigan.com</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Chavez, BS</last_name>
      <phone>616-459-7101</phone>
      <phone_ext>6140</phone_ext>
      <email>mchavez@rvorthopedics.com</email>
    </contact_backup>
    <investigator>
      <last_name>Tim R Lenters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Horneff JG 3rd, Hsu JE, Voleti PB, O'Donnell J, Huffman GR. Propionibacterium acnes infection in shoulder arthroscopy patients with postoperative pain. J Shoulder Elbow Surg. 2015 Jun;24(6):838-43. doi: 10.1016/j.jse.2015.03.008.</citation>
    <PMID>25979553</PMID>
  </reference>
  <reference>
    <citation>Levy O, Iyer S, Atoun E, Peter N, Hous N, Cash D, Musa F, Narvani AA. Propionibacterium acnes: an underestimated etiology in the pathogenesis of osteoarthritis? J Shoulder Elbow Surg. 2013 Apr;22(4):505-11. doi: 10.1016/j.jse.2012.07.007. Epub 2012 Sep 13.</citation>
    <PMID>22981447</PMID>
  </reference>
  <reference>
    <citation>Matsen FA 3rd, Butler-Wu S, Carofino BC, Jette JL, Bertelsen A, Bumgarner R. Origin of propionibacterium in surgical wounds and evidence-based approach for culturing propionibacterium from surgical sites. J Bone Joint Surg Am. 2013 Dec 4;95(23):e1811-7. doi: 10.2106/JBJS.L.01733.</citation>
    <PMID>24306704</PMID>
  </reference>
  <reference>
    <citation>Matsen FA 3rd, Russ SM, Bertelsen A, Butler-Wu S, Pottinger PS. Propionibacterium can be isolated from deep cultures obtained at primary arthroplasty despite intravenous antimicrobial prophylaxis. J Shoulder Elbow Surg. 2015 Jun;24(6):844-7. doi: 10.1016/j.jse.2014.10.016. Epub 2014 Dec 26.</citation>
    <PMID>25547858</PMID>
  </reference>
  <reference>
    <citation>Mook WR, Klement MR, Green CL, Hazen KC, Garrigues GE. The Incidence of Propionibacterium acnes in Open Shoulder Surgery: A Controlled Diagnostic Study. J Bone Joint Surg Am. 2015 Jun 17;97(12):957-63. doi: 10.2106/JBJS.N.00784.</citation>
    <PMID>26085528</PMID>
  </reference>
  <reference>
    <citation>Sethi PM, Sabetta JR, Stuek SJ, Horine SV, Vadasdi KB, Greene RT, Cunningham JG, Miller SR. Presence of Propionibacterium acnes in primary shoulder arthroscopy: results of aspiration and tissue cultures. J Shoulder Elbow Surg. 2015 May;24(5):796-803. doi: 10.1016/j.jse.2014.09.042. Epub 2014 Dec 4.</citation>
    <PMID>25483906</PMID>
  </reference>
  <reference>
    <citation>Sabetta JR, Rana VP, Vadasdi KB, Greene RT, Cunningham JG, Miller SR, Sethi PM. Efficacy of topical benzoyl peroxide on the reduction of Propionibacterium acnes during shoulder surgery. J Shoulder Elbow Surg. 2015 Jul;24(7):995-1004. doi: 10.1016/j.jse.2015.04.003.</citation>
    <PMID>26067191</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Orthopaedic Associates of Michigan, PC</investigator_affiliation>
    <investigator_full_name>Tim Lenters</investigator_full_name>
    <investigator_title>Orthopedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>Shoulder Arthroplasty</keyword>
  <keyword>C.acnes</keyword>
  <keyword>Cutibacterium acnes</keyword>
  <keyword>Irrisept</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

